Also-Ran to EpiPen Reaches for a Closing Window of Opportunity

Adrenaclick, a cheaper alternative, has benefited from furor over EpiPen pricing. But its maker is struggling to meet demand, and a generic EpiPen is near.

from NYT > Health http://ift.tt/2euMlgA
via health&fitness